share_log

Credit Suisse Downgrades Aveanna Healthcare Hldgs to Underperform, Lowers Price Target to $1

Benzinga Real-time News ·  Jan 27, 2023 07:15

Credit Suisse analyst A.J. Rice downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Neutral to Underperform and lowers the price target from $2 to $1.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment